Pivotal bioVenture Partners Investment Advisor LLC RXRX holdings history
RECURSION PHARMACEUTICALS-A · CUSIP 75629V104 · CIK 1844645
As of 2026-06-30, Pivotal bioVenture Partners Investment Advisor LLC reported 595.52K RXRX (shares), valued at $2.19M, or 0.71% of its reported non-derivative portfolio. Filed 2026-08-13.
Verify history & sources →Shares unchanged; reported value increased 19.54%, and weight changed +0.06 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.
Left: % · Right: Shares · Independently scaled axes
Exact data and methodology
Axes scale independently; a crossing does not mean equal values. Weight uses each quarter's total reported non-derivative value. Same CUSIP; missing quarters are gaps, not zero. Revised history may include later disclosures.
| Quarter | Weight | Quantity | Source |
|---|---|---|---|
| Q2 2026 | 0.71% | 595,518 | SEC filing ↗Filed Aug 13, 2026 |
| Q1 2026 | 0.65% | 595,518 | SEC filing ↗Filed May 14, 2026 |
| Q4 2025 | 0.94% | 595,518 | SEC filing ↗Filed Feb 13, 2026 |
| Q3 2025 | 1.68% | 595,518 | SEC filing ↗Filed Nov 13, 2025 |
| Q2 2025 | 1.87% | 595,518 | SEC filing ↗Filed Aug 13, 2025 |
| Q1 2025 | 2.55% | 595,518 | SEC filing ↗Filed May 14, 2025 |
| Q4 2024 | 2.72% | 595,518 | SEC filing ↗Filed Feb 13, 2025 |
| Q3 2024 | Not reported | Not reported | — |
| Q2 2024 | Not reported | Not reported | — |
| Q1 2024 | Not reported | Not reported | — |
| Q4 2023 | Not reported | Not reported | — |
History & evidence by quarter
| Quarter | Weight | Quantity | Value | Change explained | Source |
|---|---|---|---|---|---|
| Q4 2023 | Not reported | — | — | This security is absent from this quarter's filing; a missing record is not treated as zero holdings. | — |
| Q1 2024 | Not reported | — | — | This security is absent from this quarter's filing; a missing record is not treated as zero holdings. | — |
| Q2 2024 | Not reported | — | — | This security is absent from this quarter's filing; a missing record is not treated as zero holdings. | — |
| Q3 2024 | Not reported | — | — | This security is absent from this quarter's filing; a missing record is not treated as zero holdings. | — |
| Q4 2024 | 2.72% | 595,518 | $4.03M | A comparable prior-quarter record is unavailable; changes are not inferred. | SEC filing ↗ Filed Feb 13, 2025 |
| Q1 2025 | 2.55% | 595,518 | $3.15M | Shares unchanged; reported value decreased 21.75%, and weight changed -0.17 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds. | SEC filing ↗ Filed May 14, 2025 |
| Q2 2025 | 1.87% | 595,518 | $3.01M | Shares unchanged; reported value decreased 4.35%, and weight changed -0.68 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds. | SEC filing ↗ Filed Aug 13, 2025 |
| Q3 2025 | 1.68% | 595,518 | $2.91M | Shares unchanged; reported value decreased 3.56%, and weight changed -0.19 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds. | SEC filing ↗ Filed Nov 13, 2025 |
| Q4 2025 | 0.94% | 595,518 | $2.44M | Shares unchanged; reported value decreased 16.19%, and weight changed -0.74 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds. | SEC filing ↗ Filed Feb 13, 2026 |
| Q1 2026 | 0.65% | 595,518 | $1.83M | Shares unchanged; reported value decreased 24.94%, and weight changed -0.29 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds. | SEC filing ↗ Filed May 14, 2026 |
| Q2 2026 | 0.71% | 595,518 | $2.19M | Shares unchanged; reported value increased 19.54%, and weight changed +0.06 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds. | SEC filing ↗ Filed Aug 13, 2026 |
Take these holdings further.
This page includes 11 of 11 reported holdings. Sign in to look up the full history beyond 3 years, use advanced screening & filtering, download CSV, and get the complete set through the Akkru API.
- Download CSV
- Earlier quarters
- Advanced screening & filtering
- API & AI access
＋ New accounts get free API credits to explore data beyond ownership filings.
For AI agents & developers
The initial HTML of this page carries its exact data as script#research-data (JSON): values, units, scope, preview limits and SEC sources. Read it directly, no script or API key needed; script#research-access says what needs an account.
Without an account: the last 3 years, with the row caps stated on the page. A free account opens all history on file on these pages and the CSV of what a page shows. Rows beyond the caps and bulk retrieval go through the authenticated API / MCP.
MCP https://api.akkrudata.ai/mcp
get_institutional_portfolio
{"cik":"1844645","quarter":"2026Q2","cusip":"75629V104"}
get_institutional_manager_history
{"cik":"1844645","page_size":100}Connect to MCP with OAuth and follow the returned pagination. Credits and usage limits depend on the account.
- MCP endpoint
- https://api.akkrudata.ai/mcp
- API / MCP documentation
- /documents
- llms.txt
- /llms.txt
Sources, coverage & how to read this data
Figures are as reported to the SEC and merged with later amendments where Akkru could match them. Preview limits apply to what is listed, not to the totals, which come from the complete reported data. Nothing is zero-filled: a missing quarter or month is shown as missing.